Cumberland Pharmaceuticals (CPIX) Enterprise Value (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Enterprise Value of -$11.3 million for Q1 2026, up 26.48% on a YoY basis from -$9.0 million in Q1 2025, and up 3.74% sequentially from -$11.8 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Enterprise Value (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Enterprise Value data on file, last reported at -$11.3 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 26.48% year-over-year to -$11.3 million; the trailing twelve-month figure through Mar 2026 stood at -$11.3 million (up 26.48% YoY), and the FY2025 full-year result was -$11.8 million, up 35.52% from the prior year.
- Enterprise Value advanced to -$11.3 million in Q1 2026, from -$11.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$11.3 million in Q1 2026 to a low of -$20.1 million in Q4 2022.
- A 5-year average of -$17.2 million and a median of -$17.8 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value fell 12.88% in 2024 and soared 35.52% in 2025, its largest moves.
- Tracing CPIX's Enterprise Value over 5 years: stood at -$20.1 million in 2022, then increased by 6.91% to -$18.7 million in 2023, then advanced by 2.11% to -$18.3 million in 2024, then soared by 35.52% to -$11.8 million in 2025, then increased by 3.74% to -$11.3 million in 2026.
- Business Quant data shows CPIX's Enterprise Value at -$11.3 million in Q1 2026, -$11.8 million in Q4 2025, and -$15.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -11.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.34 Mn |
| Dec 31, 2025 | -11.78 Mn |
| Sep 30, 2025 | -15.52 Mn |
| Jun 30, 2025 | -16.40 Mn |
| Mar 31, 2025 | -15.42 Mn |
| Dec 31, 2024 | -18.27 Mn |
| Sep 30, 2024 | -17.77 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Mar 31, 2024 | -18.85 Mn |
| Dec 31, 2023 | -18.67 Mn |
| Sep 30, 2023 | -18.84 Mn |
| Jun 30, 2023 | -18.57 Mn |
| Mar 31, 2023 | -16.70 Mn |
| Dec 31, 2022 | -20.05 Mn |
| Sep 30, 2022 | -19.81 Mn |
| Jun 30, 2022 | -18.48 Mn |
| Mar 31, 2022 | -17.50 Mn |
| Dec 31, 2021 | -27.25 Mn |
| Sep 30, 2021 | -26.02 Mn |
| Jun 30, 2021 | -25.81 Mn |